Vilas-Boas et al. Anti-NOR antibodies. 27.5% of anti-NOR+ diagnosed with rheumatic disease - SSc and UCTD most common. @RheumNow #ACR22 Abstr#0832 https://t.co/OU2hFn3ioK https://t.co/Ve0Jbexycm
Links:
Anti-NOR 90 Antibodies: What Is the Clinical Significance in Rheumatic Inflamma…
https://acrabstracts.org/abstract/anti-nor-90-antibodies-what-is-the-clinical-s…
13-11-2022
